Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Nexteq Share News (NXQ)
NXQ Share
Price
NXQ Share
News
NXQ Share
Chat
NXQ Share
Trades17
NXQ
Live RNS
NXQ Share
Charts
NXQ Level 2
Console
NXQ Live
Share Price
NXQ Broker
Ratings
NXQ Directors
Deals
NXQ Financial
Diary
NXQ
Fundamentals
NXQ Short
Positions
NXQ
Media
NXQ Company
Research
NXQ Company
Timeline
Share Price Information for Nexteq (NXQ)
Last checked at -
Last checked at 
Intraday Nexteq Share Chart
Nexteq News
EARNINGS AND TRADING: Nexteq warns full-year revenue to miss consensus
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...
LONDON MARKET MIDDAY: Stocks move lower as war worry comes to fore
(Alliance News) - Stock prices in Europe were lower on Thursday afternoon, as eyes remain on US-Iran talks and after survey data revealed the conflict...
WINNERS & LOSERS: Sabre premiums grow; Nexteq warns on revenue
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.
EARNINGS: Goldplat to resume dividends; Nexteq watching memory prices
The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance Ne...
Nexteq wins first order for Launchpad gaming platform
(Alliance News) - Nexteq PLC on Friday secured its first customer win and initial software licence purchase order for its newly launched gaming softwa...
Nexteq lands maiden Launchpad deal with Asian gaming developer
(Sharecast News) - Technology solutions firm Nexteq has secured its first customer win and initial software license purchase order for its recently la...
LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%
(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data ...
Follow the stocks
